Ardent Health Partners (NYSE:ARDT) Reaches New 12-Month Low – What’s Next?

Ardent Health Partners, LLC (NYSE:ARDT)’s stock price reached a new 52-week low on Wednesday . The company traded as low as $13.54 and last traded at $13.73, with a volume of 108043 shares traded. The stock had previously closed at $14.20.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ARDT. Stephens reaffirmed an “overweight” rating and issued a $22.00 target price on shares of Ardent Health Partners in a research report on Thursday, February 27th. Morgan Stanley reduced their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 21st. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Truist Financial reduced their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Royal Bank of Canada reduced their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners has an average rating of “Buy” and an average target price of $21.18.

Ardent Health Partners Trading Up 5.1 %

The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company’s 50 day simple moving average is $14.81 and its 200-day simple moving average is $16.67.

Ardent Health Partners (NYSE:ARDT) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. As a group, analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Hedge Funds Weigh In On Ardent Health Partners

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health Partners during the 4th quarter valued at about $27,000. US Bancorp DE purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $31,000. R Squared Ltd purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $37,000. BNP Paribas Financial Markets purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $42,000. Finally, New York State Common Retirement Fund purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.